Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials
Author:
Affiliation:
1. Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
2. Hospital for Rheumatic Diseases, Hanyang University College of Medicine, Seoul, Korea.
Publisher
Korean Association of Internal Medicine
Link
http://synapse.koreamed.org/pdf/10.3904/kjim.2014.29.5.656
Reference21 articles.
1. Rheumatoid Arthritis
2. Genome scan meta-analysis of rheumatoid arthritis
3. Janus kinases in immune cell signaling
4. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
5. Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Meta-Analysis of Life Cycle Assessment Studies for Polyethylene Terephthalate Water Bottle System;Sustainability;2024-01-08
2. Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials;Int. Journal of Clinical Pharmacology and Therapeutics;2021-08-01
3. Actualización de las guías del tratamiento farmacológico de la artritis reumatoide del Colegio Mexicano de Reumatología 2018;Reumatología Clínica;2021-04
4. Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018;Reumatología Clínica (English Edition);2021-04
5. Optimising Response to Advanced Therapies in Rheumatoid Arthritis – Using Prehabilitation to Improve Success?;EMJ Rheumatology;2020-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3